Polly A. Murphy
Director at Atea Pharmaceuticals, Inc. (AVIR)
Purchase track record
Strong record. Based on 2 purchases with a full 90 days of price history.
84
Avg. 90-day return+28.9%
vs. S&P 500+25.1%
Beat the market100%
Paper profit on buys+$12K
Total bought / sold$51K / $0
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| May 21SEC | AVIRAtea Pharmaceuticals, Inc. | Buy | 6,10092,145 held (+7%) | $4.17 | $25K | +23.5% |
| May 20SEC | AVIRAtea Pharmaceuticals, Inc. | Buy | 6,10092,145 held (+7%) | $4.17 | $25K | +23.5% |
- Buy
Director Polly A. Murphy bought $25K of AVIR at $4.17 — first open-market purchase in our records.